NCT01884493

Brief Summary

The gait symptoms are usually refractory to the dopaminergic agents and some other resolutions, i.e. repetitive transcranial magnetic stimulation (rTMS) should be searched for in this regard. To study the impact of rTMS, investigators will adopt a domestically developed ambulatory recorder (PK-16CH EXG) for the concomitant recording of the electroencephalographic and electromyographic signals for PD patients when walking in the gait laboratory or when conducting leg dorsiflexion movement on sitting.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 24, 2013

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

August 8, 2014

Status Verified

January 1, 2014

Enrollment Period

6 months

First QC Date

June 19, 2013

Last Update Submit

August 6, 2014

Conditions

Keywords

Parkinson's DiseaseFreezing of Gaitmovement-related cortical potentialrepetitive transcranial magnetic stimulation

Outcome Measures

Primary Outcomes (1)

  • Change in Laboratory gait analysis after 8 courses of iTBS

    Variables in gait analysis:1.Gait initiation; 2.Level walking; 3.Turning; 4.Gait termination.

    baseline to week 8

Secondary Outcomes (7)

  • Change in Unified Parkinson's Disease Rating Scale (UPDRS) after 8 courses of iTBS

    baseline to week 8

  • Change in The 39-item Parkinson's Disease Questionnaire (PDQ-39) after 8 courses of iTBS

    baseline to week 8

  • Change in Fall assessment test after 8 courses

    baseline to week 8

  • Change in Tinetti's Mobility Index after 8 courses of iTBS

    baseline to week 8

  • Change in new freezing of gait questionnaire (FOG-Q) after 8 courses

    baseline to week 8

  • +2 more secondary outcomes

Study Arms (2)

real iTBS

EXPERIMENTAL

The paradigm will use a theta burst stimulation pattern (TBS) in which 3 pulses of stimulation will be given at 50Hz, repeated every 200 ms. In the iTBS, a 2-second train of TBS is repeated every 10 seconds for a total of 190 seconds (600 pulses). Subjects will be 8 courses of iTBS stimulation in 10 business days.

Device: real iTBSDevice: sham iTBS

sham iTBS

SHAM COMPARATOR

Subjects will be 8 courses of sham iTBS stimulation in 10 business days.

Device: real iTBSDevice: sham iTBS

Interventions

real iTBSDEVICE

Theta-burst magnetic stimulation (TBS) is a repetitive transcranial magnetic stimulation (rTMS) technique that elicits long-lasting changes in the excitability of human primary motor cortex (M1).

real iTBSsham iTBS
sham iTBSDEVICE

The sham test will be done by transferring the double cone coil 90 degrees anteriorly and putting the lower edge of the coil of the vertex.

real iTBSsham iTBS

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with PD will be diagnosed according to the Brain Bank criteria.

You may not qualify if:

  • Patients had past history of epilepsy, intracranial operation or brain tumor.
  • Hoehn \& Yahr Stage V.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital/Neuro Depart

Taichung, Taiwan

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The chief, Department of Neurology

Study Record Dates

First Submitted

June 19, 2013

First Posted

June 24, 2013

Study Start

January 1, 2014

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

August 8, 2014

Record last verified: 2014-01

Locations